The low expression of IGF-1 served as a favorable prognostic factor in some cancer types, including BLCA, CHOL, LAML, and UVM; whereas in SARC, high expression of IGF-1 served as a favorable prognostic factor. Here, IGF1 is linked to bladder transitional cell carcinoma.